{"id":483012,"date":"2021-04-28T06:53:18","date_gmt":"2021-04-28T10:53:18","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/elizabeth-mccombs-appointed-chief-technology-officer-at-bd\/"},"modified":"2021-04-28T06:53:18","modified_gmt":"2021-04-28T10:53:18","slug":"elizabeth-mccombs-appointed-chief-technology-officer-at-bd","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/elizabeth-mccombs-appointed-chief-technology-officer-at-bd\/","title":{"rendered":"Elizabeth McCombs Appointed Chief Technology Officer at BD"},"content":{"rendered":"<div class=\"xn-newslines\">\n<h2 class=\"xn-hedline\">John DeFord to join newly formed external Scientific Advisory Board<\/h2>\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">FRANKLIN LAKES, N.J.<\/span>, <span class=\"xn-chron\">April 28, 2021<\/span> \/PRNewswire\/ &#8212;\u00a0BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of <span class=\"xn-person\">Elizabeth McCombs<\/span> as executive vice president and chief technology officer, effective <span class=\"xn-chron\">April 26, 2021<\/span>, succeeding <span class=\"xn-person\">John DeFord<\/span>. <\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/1498460\/Elizabeth_McCombs.html\" target=\"_blank\" rel=\"nofollow noopener\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1498460\/Elizabeth_McCombs.jpg\" title=\"Elizabeth McCombs has been appointed executive vice president and chief technology officer of BD, effective April 26, 2021, succeeding John DeFord.\" alt=\"Elizabeth McCombs has been appointed executive vice president and chief technology officer of BD, effective April 26, 2021, succeeding John DeFord.\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>McCombs, 45, will be responsible for continuing to drive the company&#8217;s category innovation strategy and leading all research and development (R&amp;D) activities, including executing the current innovation pipeline and developing the future product portfolio.<\/p>\n<p>&#8220;Beth has been an influential leader since joining BD, leading R&amp;D for the Medical Segment to achieve all key innovation and execution metrics with significant improvement over prior years,&#8221; said <span class=\"xn-person\">Tom Polen<\/span>, chairman, CEO and president of BD. &#8220;She has served as a highly impactful R&amp;D sponsor for our top Medical segment priorities, while co-leading the segment portfolio strategy and growth acceleration initiatives. In addition, Beth has helped to prioritize and redirect investments toward high-growth spaces that will accelerate category innovation across the Medical Segment businesses, with a focus on smart connected devices.&#8221;<\/p>\n<p>McCombs, who brings more than 20 years of extensive experience in advanced medical device innovation to her new role, joined BD in 2019 as the senior vice president of R&amp;D for the BD Medical Segment. She began her career at Johnson &amp; Johnson (J&amp;J) Ethicon Endo-Surgery and progressed through positions of increasing leadership responsibility, including director for the J&amp;J Corporate Office of Science and Technology (COSAT), focused on external technology partnerships; R&amp;D leader for the J&amp;J Sports Medicine business; vice president of Surgical Innovation for the Ethicon franchise; and most recently, as vice president of R&amp;D for Ethicon, while also leading China R&amp;D and Industrial Design\/Human Factors for all of J&amp;J Medical Devices. \u00a0Aside from her technical credentials, Beth has been recognized for her work driving inclusion and diversity efforts, including the support and mentorship of fellow female professionals.<\/p>\n<p>&#8220;BD is making great strides in shifting our R&amp;D portfolio toward high impact opportunities like smart connected devices, enabling new care settings, and improving diagnosis and treatment for chronic diseases,&#8221; said McCombs. &#8220;We will continue to advance an insight-driven innovation strategy and accelerate external technology partnerships and investments to increase the velocity and value creation of the innovation funnel, and we are committed to deliver the best customer outcomes and return on investment.&#8221; <\/p>\n<p>McCombs holds both a Bachelor of Science and a Master of Science in Mechanical Engineering from the <span class=\"xn-org\">Massachusetts Institute of Technology<\/span>, and a Master of Business Administration from the <span class=\"xn-org\">University of Pennsylvania&#8217;s<\/span> Wharton School of Business.<\/p>\n<p>\n        <b>Scientific Advisory Board<\/b><br \/>\n        <br \/>BD also announced the creation of an external Scientific Advisory Board (SAB), which will be comprised of top medical key opinion leaders, science and technology experts and experienced innovation leaders. The SAB will meet to review BD&#8217;s technology capabilities, innovation pipeline, tuck-in M&amp;A opportunities and early-stage investments. The SAB will also advise BD&#8217;s leadership on its growth prioritization as well as emerging trends in health care, science and technology, and the potential implications for BD. <\/p>\n<p>\n        <span class=\"xn-person\">John DeFord<\/span>, following his retirement from BD on <span class=\"xn-chron\">May 28, 2021<\/span>, will be a founding member and co-chair of the SAB. DeFord brings 35 years of extensive industry experience to the SAB as well as in-depth knowledge of BD&#8217;s R&amp;D and business priorities. DeFord earned his bachelor&#8217;s degree and master&#8217;s degree in Electrical Engineering from <span class=\"xn-org\">Purdue University<\/span>, where he also earned a doctorate in Electrical\/Biomedical Engineering.<\/p>\n<p>\n        <b>About BD<\/b><br \/>\n        <br \/>BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians&#8217; care delivery process, enable laboratory scientists to accurately detect disease and advance researchers&#8217; capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3144436-1&amp;h=2790847843&amp;u=http%3A%2F%2Fwww.bd.com%2F&amp;a=bd.com\" rel=\"nofollow noopener\">bd.com<\/a> or connect with us on LinkedIn at <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3144436-1&amp;h=3303744975&amp;u=http%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fbd1%2F&amp;a=www.linkedin.com%2Fcompany%2Fbd1%2F\" rel=\"nofollow noopener\">www.linkedin.com\/company\/bd1\/<\/a> and Twitter <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3144436-1&amp;h=1214714453&amp;u=https%3A%2F%2Ftwitter.com%2Fbdandco&amp;a=%40BDandCo\" rel=\"nofollow noopener\">@BDandCo<\/a>. <\/p>\n<div>\n<table id=\"convertedTable2871\" cellspacing=\"0\" cellpadding=\"0\" border=\"0\" class=\"prnsbt0 prnsbr0 prnbcc prnsbb0 prnsbl0\">\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\"><br \/>\n                  <b>Contacts:<\/b><br \/>\n                <\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\">\n              \n            <\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\">\n              \n            <\/td>\n<td class=\"prngen2\">\n              \n            <\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\"><br \/>\n                  <b>Media<\/b><br \/>\n                <\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\"><br \/>\n                  <b>Investors<\/b><br \/>\n                <\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">Troy Kirkpatrick<\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">Kristen M. Stewart, CFA<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">VP, Public Relations<\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">SVP, Strategy &amp; Investor Relations<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">858.617.2361<\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">201.847.5378\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\"><br \/>\n                  <a target=\"_blank\" href=\"mailto:troy.kirkpatrick@bd.com\" class=\"prnews_a\" rel=\"nofollow noopener\">troy.kirkpatrick@bd.com<\/a><br \/>\n                <\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\"><br \/>\n                  <a target=\"_blank\" href=\"mailto:kristen.stewart@bd.com\" class=\"prnews_a\" rel=\"nofollow noopener\">kristen.stewart@bd.com<\/a>\u00a0\u00a0 <\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n<p>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/1498461\/John_DeFord2.html\" target=\"_blank\" rel=\"nofollow noopener\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1498461\/John_DeFord2.jpg\" title=\"John DeFord, following his retirement from BD on May 28, 2021, will be a founding member and co-chair of BD's newly formed external Scientific Advisory Board (SAB). DeFord brings 35 years of extensive industry experience to the SAB as well as in-depth knowledge of BD\u2019s R&amp;D and business priorities.\" alt=\"John DeFord, following his retirement from BD on May 28, 2021, will be a founding member and co-chair of BD's newly formed external Scientific Advisory Board (SAB). DeFord brings 35 years of extensive industry experience to the SAB as well as in-depth knowledge of BD\u2019s R&amp;D and business priorities.\" \/><br \/>\n          <\/a>\n        <\/p>\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/1479210\/BD_Logo.html\" target=\"_blank\" rel=\"nofollow noopener\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1479210\/BD_Logo.jpg\" title=\"BD (Becton, Dickinson and Company) Logo (PRNewsfoto\/BD (Becton, Dickinson and Company))\" alt=\"BD (Becton, Dickinson and Company) Logo (PRNewsfoto\/BD (Becton, Dickinson and Company))\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY58327&amp;sd=2021-04-28\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/elizabeth-mccombs-appointed-chief-technology-officer-at-bd-301278622.html\">http:\/\/www.prnewswire.com\/news-releases\/elizabeth-mccombs-appointed-chief-technology-officer-at-bd-301278622.html<\/a><\/p>\n<p>SOURCE  BD (Becton, Dickinson and Company)<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NY58327&amp;Transmission_Id=202104280650PR_NEWS_USPR_____NY58327&amp;DateId=20210428\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>John DeFord to join newly formed external Scientific Advisory Board PR Newswire FRANKLIN LAKES, N.J., April 28, 2021 \/PRNewswire\/ &#8212;\u00a0BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of Elizabeth McCombs as executive vice president and chief technology officer, effective April 26, 2021, succeeding John DeFord. McCombs, 45, will be responsible for continuing to drive the company&#8217;s category innovation strategy and leading all research and development (R&amp;D) activities, including executing the current innovation pipeline and developing the future product portfolio. &#8220;Beth has been an influential leader since joining BD, leading R&amp;D for the Medical Segment to achieve all key innovation and execution metrics with significant improvement over prior years,&#8221; said Tom Polen, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/elizabeth-mccombs-appointed-chief-technology-officer-at-bd\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Elizabeth McCombs Appointed Chief Technology Officer at BD&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-483012","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Elizabeth McCombs Appointed Chief Technology Officer at BD - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/elizabeth-mccombs-appointed-chief-technology-officer-at-bd\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Elizabeth McCombs Appointed Chief Technology Officer at BD - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"John DeFord to join newly formed external Scientific Advisory Board PR Newswire FRANKLIN LAKES, N.J., April 28, 2021 \/PRNewswire\/ &#8212;\u00a0BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of Elizabeth McCombs as executive vice president and chief technology officer, effective April 26, 2021, succeeding John DeFord. McCombs, 45, will be responsible for continuing to drive the company&#8217;s category innovation strategy and leading all research and development (R&amp;D) activities, including executing the current innovation pipeline and developing the future product portfolio. &#8220;Beth has been an influential leader since joining BD, leading R&amp;D for the Medical Segment to achieve all key innovation and execution metrics with significant improvement over prior years,&#8221; said Tom Polen, &hellip; Continue reading &quot;Elizabeth McCombs Appointed Chief Technology Officer at BD&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/elizabeth-mccombs-appointed-chief-technology-officer-at-bd\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-28T10:53:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1498460\/Elizabeth_McCombs.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elizabeth-mccombs-appointed-chief-technology-officer-at-bd\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elizabeth-mccombs-appointed-chief-technology-officer-at-bd\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Elizabeth McCombs Appointed Chief Technology Officer at BD\",\"datePublished\":\"2021-04-28T10:53:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elizabeth-mccombs-appointed-chief-technology-officer-at-bd\\\/\"},\"wordCount\":826,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elizabeth-mccombs-appointed-chief-technology-officer-at-bd\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1498460\\\/Elizabeth_McCombs.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elizabeth-mccombs-appointed-chief-technology-officer-at-bd\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elizabeth-mccombs-appointed-chief-technology-officer-at-bd\\\/\",\"name\":\"Elizabeth McCombs Appointed Chief Technology Officer at BD - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elizabeth-mccombs-appointed-chief-technology-officer-at-bd\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elizabeth-mccombs-appointed-chief-technology-officer-at-bd\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1498460\\\/Elizabeth_McCombs.jpg\",\"datePublished\":\"2021-04-28T10:53:18+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elizabeth-mccombs-appointed-chief-technology-officer-at-bd\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elizabeth-mccombs-appointed-chief-technology-officer-at-bd\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elizabeth-mccombs-appointed-chief-technology-officer-at-bd\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1498460\\\/Elizabeth_McCombs.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1498460\\\/Elizabeth_McCombs.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elizabeth-mccombs-appointed-chief-technology-officer-at-bd\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Elizabeth McCombs Appointed Chief Technology Officer at BD\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Elizabeth McCombs Appointed Chief Technology Officer at BD - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/elizabeth-mccombs-appointed-chief-technology-officer-at-bd\/","og_locale":"en_US","og_type":"article","og_title":"Elizabeth McCombs Appointed Chief Technology Officer at BD - Market Newsdesk","og_description":"John DeFord to join newly formed external Scientific Advisory Board PR Newswire FRANKLIN LAKES, N.J., April 28, 2021 \/PRNewswire\/ &#8212;\u00a0BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of Elizabeth McCombs as executive vice president and chief technology officer, effective April 26, 2021, succeeding John DeFord. McCombs, 45, will be responsible for continuing to drive the company&#8217;s category innovation strategy and leading all research and development (R&amp;D) activities, including executing the current innovation pipeline and developing the future product portfolio. &#8220;Beth has been an influential leader since joining BD, leading R&amp;D for the Medical Segment to achieve all key innovation and execution metrics with significant improvement over prior years,&#8221; said Tom Polen, &hellip; Continue reading \"Elizabeth McCombs Appointed Chief Technology Officer at BD\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/elizabeth-mccombs-appointed-chief-technology-officer-at-bd\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-28T10:53:18+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1498460\/Elizabeth_McCombs.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/elizabeth-mccombs-appointed-chief-technology-officer-at-bd\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/elizabeth-mccombs-appointed-chief-technology-officer-at-bd\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Elizabeth McCombs Appointed Chief Technology Officer at BD","datePublished":"2021-04-28T10:53:18+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/elizabeth-mccombs-appointed-chief-technology-officer-at-bd\/"},"wordCount":826,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/elizabeth-mccombs-appointed-chief-technology-officer-at-bd\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1498460\/Elizabeth_McCombs.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/elizabeth-mccombs-appointed-chief-technology-officer-at-bd\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/elizabeth-mccombs-appointed-chief-technology-officer-at-bd\/","name":"Elizabeth McCombs Appointed Chief Technology Officer at BD - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/elizabeth-mccombs-appointed-chief-technology-officer-at-bd\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/elizabeth-mccombs-appointed-chief-technology-officer-at-bd\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1498460\/Elizabeth_McCombs.jpg","datePublished":"2021-04-28T10:53:18+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/elizabeth-mccombs-appointed-chief-technology-officer-at-bd\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/elizabeth-mccombs-appointed-chief-technology-officer-at-bd\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/elizabeth-mccombs-appointed-chief-technology-officer-at-bd\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1498460\/Elizabeth_McCombs.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1498460\/Elizabeth_McCombs.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/elizabeth-mccombs-appointed-chief-technology-officer-at-bd\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Elizabeth McCombs Appointed Chief Technology Officer at BD"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/483012","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=483012"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/483012\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=483012"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=483012"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=483012"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}